全文获取类型
收费全文 | 6504篇 |
免费 | 475篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 102篇 |
妇产科学 | 64篇 |
基础医学 | 1059篇 |
口腔科学 | 44篇 |
临床医学 | 778篇 |
内科学 | 1793篇 |
皮肤病学 | 89篇 |
神经病学 | 615篇 |
特种医学 | 226篇 |
外科学 | 867篇 |
综合类 | 20篇 |
预防医学 | 505篇 |
眼科学 | 46篇 |
药学 | 383篇 |
中国医学 | 9篇 |
肿瘤学 | 358篇 |
出版年
2023年 | 31篇 |
2022年 | 44篇 |
2021年 | 179篇 |
2020年 | 89篇 |
2019年 | 162篇 |
2018年 | 182篇 |
2017年 | 106篇 |
2016年 | 119篇 |
2015年 | 182篇 |
2014年 | 255篇 |
2013年 | 300篇 |
2012年 | 498篇 |
2011年 | 488篇 |
2010年 | 285篇 |
2009年 | 256篇 |
2008年 | 441篇 |
2007年 | 450篇 |
2006年 | 430篇 |
2005年 | 451篇 |
2004年 | 415篇 |
2003年 | 415篇 |
2002年 | 409篇 |
2001年 | 73篇 |
2000年 | 63篇 |
1999年 | 88篇 |
1998年 | 89篇 |
1997年 | 59篇 |
1996年 | 49篇 |
1995年 | 51篇 |
1994年 | 42篇 |
1993年 | 19篇 |
1992年 | 28篇 |
1991年 | 27篇 |
1990年 | 38篇 |
1989年 | 27篇 |
1988年 | 29篇 |
1987年 | 23篇 |
1986年 | 21篇 |
1985年 | 12篇 |
1984年 | 13篇 |
1983年 | 10篇 |
1982年 | 8篇 |
1981年 | 4篇 |
1980年 | 4篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1975年 | 4篇 |
1973年 | 7篇 |
1971年 | 6篇 |
1966年 | 3篇 |
排序方式: 共有7011条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
95.
Geeta Ramesh Juan T Borda Amy Gill Erin P Ribka Lisa A Morici Peter Mottram Dale S Martin Mary B Jacobs Peter J Didier Mario T Philipp 《Journal of neuroinflammation》2009,6(1):23-16
Background
Lyme neuroborreliosis (LNB) may present as meningitis, cranial neuropathy, acute radiculoneuropathy or, rarely, as encephalomyelitis. We hypothesized that glia, upon exposure to Borrelia burgdorferi, the Lyme disease agent, produce inflammatory mediators that promote the acute cellular infiltration of early LNB. This inflammatory context could potentiate glial and neuronal apoptosis. 相似文献96.
Dominique Lacroix Fran?ois Brigadeau Christelle Marquié Didier Klug 《Europace : European pacing, arrhythmias, and cardiac electrophysiology》2004,6(4):336-342
Two cases of systemic sclerosis with sustained ventricular tachycardia (VT) are presented. The first patient received hydroxychloroquine for skeletal muscle disease coexisting with cardiac involvement. In both cases, 3D-electroanatomic mapping showed low-voltage areas in the right ventricle. In the first patient the tachycardia was mapped and a protected isthmus suggesting reentry was delineated and ablated. Other substrate locations were indirectly identified by pacemapping on the right and left ventricular endocardium in the second patient. VT did not reoccur during follow-up. Radiofrequency catheter ablation is safe and effective and electroanatomic mapping may be helpful in patients with systemic sclerosis. 相似文献
97.
98.
In patients with cirrhosis, acute renal failure is mainly due to prerenal failure (caused by renal hypoperfusion) and tubular necrosis. The main causes of prerenal failure are "true hypovolemia" (induced by hemorrhage or gastrointestinal or renal fluid losses), sepsis, or type 1 hepatorenal syndrome (HRS). The frequency of prerenal failure due to the administration of nonsteroidal anti-inflammatory drugs or intravascular radiocontrast agents is unknown. Prerenal failure is rapidly reversible after restoration of renal blood flow. Treatment is directed to the cause of hypoperfusion, and fluid replacement is used to treat most cases of "non-HRS" prerenal failure. In patients with type 1 HRS with very low short-term survival rate, liver transplantation is the ideal treatment. Systemic vasoconstrictor therapy (with terlipressin, noradrenaline, or midodrine [combined with octreotide]) may improve renal function in patients with type 1 HRS waiting for liver transplantation. MARS (for molecular adsorbent recirculating system) and the transjugular intrahepatic portosystemic shunt may also improve renal function in these patients. In patients with cirrhosis, acute tubular necrosis is mainly due to an ischemic insult to the renal tubules. The most common condition leading to ischemic acute tubular necrosis is severe and sustained prerenal failure. Little is known about the natural course and treatment (i.e., renal replacement therapy) of cirrhosis-associated acute tubular necrosis. 相似文献
99.
100.
Nguyen TH Mai G Villiger P Oberholzer J Salmon P Morel P Bühler L Trono D 《Journal of hepatology》2005,43(6):1031-1037
BACKGROUND/AIMS: Liver failure is a life threatening condition currently treated by palliative measures and, when applicable, organ transplantation. The use of a bioartificial organ capable of fulfilling the main functions of the liver would represent an attractive alternative. However, the shortage of suitable donor cells, and their limited growth ability have impeded the development of this strategy. We investigated whether lentiviral vectors allow for conditional immortalization of human hepatocytes and whether these immortalized hepatocytes could reverse lethal acute liver failure. METHODS: We exposed primary human hepatocytes to Cre-excisable lentiviral vectors coding for SV40T Antigen, telomerase, and/or Bmi-1 and tested the functionality of the resulting cell lines. Therapeutic potential of immortalized hepatocytes were tested in a murine model of acetaminophen-induced hepatic injury. RESULTS: The immortalized hepatocytes grew continuously yet were non-tumorigenic, stopped proliferating when exposed to Cre recombinase, and conserved defining properties of primary hepatocytes, including the ability to secrete liver-specific proteins and to detoxify drugs. The implantation of encapsulated immortalized human hepatocytes rescued mice from lethal doses of acetaminophen. CONCLUSIONS: Lentiviral vectors represent tools of choice for immortalization of non-dividing primary cells, and lentivirally immortalized human hepatocytes are promising reagents for cell-based therapy of acute liver failure. 相似文献